Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NAD

This article was originally published in The Tan Sheet

Executive Summary

Case against Global Vision 2021 will move to FTC after advertising statements for firm's Avacor Hair Growth System remain unsubstantiated following 15-day warning letter, CBBB division says. Print ads, online promotional materials at issue claim Avacor "stops DHT from attacking hair follicles and is guaranteed to start regrowing hair in balding areas," and "in five years of clinical testing, Avacor has shown a 90% success rate in both men and women." NAD referred case to FTC after Global Vision failed to provide requested clinical studies
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS093176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel